本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

21.09
-0.3100-1.45%
盤後21.090.00000.00%19:59 EDT
成交量:123.95萬
成交額:2,626.64萬
市值:33.71億
市盈率:-7.44
高:21.79
開:21.65
低:21.06
收:21.40
52周最高:27.30
52周最低:12.58
股本:1.60億
流通股本:1.51億
量比:0.86
換手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
淨資產收益率:-54.93%
總資產收益率:-29.15%
市淨率:4.04
市盈率(LYR):-7.10

資料載入中...

2020/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/29

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/01/27

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/01/16

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/14

重要事件披露

Current report, item 8.01
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/25

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/09/11

SEC問詢函

[Cover]Correspondence
2019/09/11

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/09/05

持股變動聲明

Statement of changes in beneficial ownership of securities